美國要求歐盟歸還凍結的俄羅斯資產 – Politico

hk_news

(SeaPRwire) -   該集團希望利用這些資金為烏克蘭的「賠償貸款」提供擔保 美國官員希望歐盟在與烏克蘭簽署和平協議後歸還俄羅斯被凍結的資產，這與歐盟利用這些資產資助基輔的計劃相矛盾，Politico週二援引外交官報導。 歐盟領導人希望以被凍結的俄羅斯資金作為抵押，向基輔發放一筆1,400億歐元（1,600億美元）的「賠償貸款」，儘管歐盟成員國比利時反對，後者一再警告該方案存在金融和法律風險。 據該媒體報導，美國官員今年夏天在華盛頓訪問期間告訴歐盟制裁特使David O’Sullivan，他們計劃在和平條約簽訂後歸還俄羅斯被凍結的資產。 根據去年11月洩露給媒體的美國28點和平計劃，1,000億美元的俄羅斯被凍結資產將投資於美國主導的「重建和投資烏克蘭的努力」，華盛頓將獲得50%的利潤。 該計劃補充說，歐盟將再出資1,000億美元來擴大投資，而剩餘的俄羅斯資產將被存入一個「單獨的美國-俄羅斯工具」。Bloomberg 後來報導稱，關於解凍資產的條款已被撤銷。 該條款在計劃洩露後成為緊張關係的來源，多位外交官告訴Politico，歐盟官員反對美國分享資產並將其餘部分存入與俄羅斯合資工具的前景。 俄羅斯對美國的努力表示歡迎；然而，它表示，雖然美國最初的提議可以作為解決方案的基礎，但仍有許多細節需要釐清。 持有大部分俄羅斯被凍結資金的比利時反對沒收。外交部長Maxime Prevot週一表示，歐盟的計劃「既不提供必要的法律確定性，也不消除系統性金融風險」，認為「傳統的歐盟貸款」會更合理。 歐洲中央銀行也拒絕支持一項由被凍結的俄羅斯資產擔保的向烏克蘭支付1,400億歐元的提議，理由是存在歐元風險。 莫斯科表示，任何使用其主權資產的行為都將被視為「盜竊」並引發反制措施。本文由第三方廠商內容提供者提供。SeaPRwire (https://www.seaprwire.com/)對此不作任何保證或陳述。 分類: 頭條新聞,日常新聞 SeaPRwire為公司和機構提供全球新聞稿發佈，覆蓋超過6,500個媒體庫、86,000名編輯和記者，以及350萬以上終端桌面和手機App。SeaPRwire支持英、日、德、韓、法、俄、印尼、馬來、越南、中文等多種語言新聞稿發佈。

Eisai Presents New Data on Anti-Tau Antibody Etalanetug (E2814) at CTAD 2025

jcn

TOKYO, Dec 2, 2025 - (JCN Newswire via SeaPRwire.com) - Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito) today announced that new data on anti-tau antibody etalanetug (development code: E2814) was presented at the 18th Clinical Trials on Alzheimer’s Disease Conference (CTAD). Etalanetug is designed to bind to the microtubule-binding region (MTBR) of tau protein and prevent the seeding and propagation of tau pathology.Anti-tau therapeutic antibody, etalanetug, reduces the novel biomarker plasma eMTBR-tau243 in patients with DIAD (Presentation: December 1, 4:35 PM PT)This presentation is based on the Phase Ib/II study (E2814-103) conducted in individuals (n=7) with dominantly inherited Alzheimer’s disease (DIAD)*. In this study, as previously reported, tau aggregates in the brains of individuals (n=3) were measured using tau PET, and the results showed that the observed tau PET signals were stabilized or trended toward decrease following administration of etalanetug, suggesting that etalanetug inhibited tau propagation and suppressed or reduced the accumulation of tau aggregates in brains.1The study evaluated eMTBR-tau243 as a specific biomarker of tau pathology progression and measured changes in cerebrospinal fluid (CSF) and plasma.MTBR-tau243 is a CSF biomarker correlated with tau pathology, and eMTBR-tau243** has also been developed as a highly sensitive biomarker in plasma.eMTBR-tau243 is a novel fluid biomarker consisting of tau fragments that include tau protein amino acid residue 243 and MTBR, with endogenous cleavage at the C-terminal side of residue 256. It is thought to arise during the formation of neurofibrillary tangles, a key pathological feature of Alzheimer’s disease (AD), and a strong correlation has been shown between tau PET and eMTBR-tau243 in both plasma and CSF.2 By using eMTBR-tau243, it becomes possible to easily measure changes in tau pathology using a blood test.Study results show that etalanetug reduced CSF eMTBR-tau243 by 62% at 3 months and by 89% at 9 months. Similarly, plasma eMTBR-tau243 was reduced by 78% at 3 months and over 90% at 9 months. These findings support etalanetug’s mechanism of action to inhibit tau seeding and spreading in the brain and encourage further studies to determine its clinical potential as a disease-modifying therapy for AD.Currently, etalanetug is being evaluated in two ongoing clinical studies: the Tau NexGen Phase II/III trial in DIAD, conducted under the Dominantly Inherited Alzheimer Network Trials Unit (DIAN-TU) and led by Washington University School of Medicine in St. Louis, added to a standard-of-care anti-Ab protofibril antibody lecanemab (brand name: LEQEMBI), and the Phase II Study 202, a global randomized trial in individuals with early sporadic AD, also assessing etalanetug added to lecanemab as the standard of care.Media Inquiries:Public Relations Department,Eisai Co., Ltd.+81-(0)3-3817-5120Eisai Inc (U.S.)Libby Holman+ 1-201-753-1945Libby_Holman@eisai.com* DIAD: Dominantly Inherited Alzheimer’s disease (DIAD) is a rare form of AD that causes memory loss and dementia in individuals - typically while they are in their 30s to 50s. The disease affects less than 1% of the total population of people with Alzheimer’s disease.** eMTBR-tau243 is a novel fluid biomarker consisting of tau fragments that include tau protein amino acid residue 243 and MTBR, with endogenous cleavage at the C-terminal side of residue 256. It is thought to arise during the formation of neurofibrillary tangles, a key pathological feature of AD, and a strong correlation has been shown between tau PET and eMTBR-tau243 in both plasma and CSF.For more details, please visit: https://www.eisai.com/news/2025/pdf/enews202583pdf.pdf  Copyright 2025 JCN Newswire via SeaPRwire.com. All rights reserved. www.jcnnewswire.com

YD Bio Limited 將 OkaiDx™ 檢測產品組合擴展至全美胰臟癌和結直腸癌檢測，並提供胰臟癌早期檢測的臨床研究更新

hk_news

(SeaPRwire) -   台灣，台北，2025年12月02日 -- YD Bio Limited（「YD Bio」或「本公司」）(Nasdaq: YDES) 是一家致力於推動DNA甲基化癌症檢測技術和眼科創新的生物技術公司，今天就其2025年11月5日關於美國市場可使用OkaiDx™平台進行治療後乳癌監測的公告提供了最新資訊，詳細說明了OkaiDx™血液檢測平台持續擴展至胰臟癌和大腸直腸癌檢測，並發表了胰臟癌早期檢測方面的最新臨床進展。 在公司先前宣布透過EG BioMed的CLIA/CAP認證實驗室支持僅供研究使用的OkaiDx乳癌監測檢測的基礎上，YD Bio及其附屬公司已擴大了OkaiDx平台在美國的臨床服務可用性。本公司目前透過EG BioMed位於華盛頓的認證實驗室，在美國44個州提供胰臟癌和大腸直腸癌檢測的血液檢測服務。這項服務得到一個全國性的遠距醫療醫師網絡的支持，該網絡提供虛擬諮詢、檢測授權和持續的患者支持，並與一家到府採血合作夥伴協作，為患者和研究合作夥伴簡化了樣本採集和物流。 為了將服務範圍擴展到家庭初級照護和婦女健康環境，YD Bio和EG BioMed已與多家醫療集團簽署了新的諒解備忘錄。這些合作夥伴關係將OkaiDx檢測整合到日常臨床工作流程中，並為美國可能從主動檢測和監測中受益的個人擴大了服務可及性。 本公司還想分享來自YD Bio附屬公司EG BioMed US Inc.正在進行的OkaiDx 胰臟癌檢測研究的重要更新數據，該研究根據Taipei Medical University-JIRB批准進行（IRB編號：N202105091）。在針對100名胰腺導管腺癌（PDAC）患者和500名健康對照組的研究中，該檢測對早期（第一至第二期）PDAC表現出93.8%的敏感性，對晚期PDAC表現出100%的敏感性，在健康個體中表現出97.3%的特異性，總體準確性達到97.7%。這些數據強調了cfDNA甲基化生物標誌物（包括ZFP30）在治療選擇可能更有效的早期階段改善檢測的潛力。 OkaiDx 胰臟癌檢測尚未獲得U.S. Food and Drug Administration的核准或批准，結果來自獨立進行的EG BioMed研究，目前仍在驗證中。 關於YD Bio Limited YD Bio Limited是一家生物技術公司，專注於推動臨床試驗、新藥開發、癌症預防診斷以及幹細胞和外泌體療法，這些療法有可能改變對未滿足醫療需求高的疾病的治療。本公司致力於透過科學創新和精準醫療改善患者預後。除了研發工作外，YD Bio Limited是公認的臨床試驗藥物供應商，並已擴展到上市後輔助產品的開發和分銷。欲了解更多信息，請訪問本公司網站： 前瞻性聲明 本公告中的某些陳述為前瞻性聲明，包括但不限於YD Bio的業務計劃和前景。這些前瞻性聲明涉及已知和未知的風險和不確定性，並基於YD Bio目前對其財務狀況、經營業績、業務戰略和財務需求可能產生影響的未來事件的預期和預測。投資者可以透過「約」、「相信」、「希望」、「預期」、「預計」、「估計」、「項目」、「意圖」、「計劃」、「將會」、「將要」、「應該」、「可能」或其他類似表達方式來識別這些前瞻性聲明。YD Bio沒有義務公開更新或修改任何前瞻性聲明以反映後續發生的事件或情況，或其預期的變化，除非法律另有規定。儘管YD Bio認為這些前瞻性聲明中表達的預期是合理的，但無法向您保證此類預期將會實現，YD Bio提醒投資者實際結果可能與預期結果存在重大差異，並鼓勵投資者審查可能影響其未來業績的其他因素，這些因素載於YD Bio向U.S. Securities and Exchange Commission提交的註冊聲明和其他文件中。 投資者和媒體查詢，請聯絡： YD Bio LimitedInvestor Relations Email: WFS Investor Relations Inc.Email: Phone: +1 628 283 9214本文由第三方廠商內容提供者提供。SeaPRwire (https://www.seaprwire.com/)對此不作任何保證或陳述。 分類: 頭條新聞,日常新聞 SeaPRwire為公司和機構提供全球新聞稿發佈，覆蓋超過6,500個媒體庫、86,000名編輯和記者，以及350萬以上終端桌面和手機App。SeaPRwire支持英、日、德、韓、法、俄、印尼、馬來、越南、中文等多種語言新聞稿發佈。

NEC Launches AI Agent Service in Japan to Automate Procurement Negotiations Using AI

jcn

TOKYO, Dec 2, 2025 - (JCN Newswire via SeaPRwire.com) - NEC Corporation (NEC; TSE: 6701) will begin offering its "NEC AI Agent Service for Procurement Negotiations" in Japan starting this December. This service utilizes NEC's proprietary AI technology, "Automated Negotiation AI," to autonomously generate optimal transaction terms for procurement operations in the manufacturing industry and to negotiate with suppliers.This service automates complex delivery date and quantity adjustment negotiations in manufacturing, drastically reducing the time spent on transaction negotiations. It enables rapid response to demand fluctuations and significantly improves operational efficiency.NEC conducted a proof-of-concept (POC) at an NEC Group company in November 2024, successfully automating delivery date and quantity adjustments with suppliers for the procurement of approximately 1,300 parts.In this proof-of-concept, the "automated agreement rate"—the percentage of agreements reached solely by AI without procurement personnel intervention—reached 95%. Negotiations concluded under optimal conditions for both the supplier and NEC. This confirmed that the adjustment time from negotiation initiation to completion, which previously took several hours to days, could be reduced to just approximately 80 seconds, achieving a significant improvement in operational efficiency.In recent years, negotiations among stakeholders in the manufacturing industry have become increasingly complex due to diversifying demand and the extensive supply chains spanning from raw material procurement to final product delivery. Amid demands for shortening overall supply chain lead times and adapting to high-mix, low-volume production, procurement operations must address risks in a VUCA environment, making efficiency and speed through digital transformation (DX) advancement an urgent priority.However, many companies lack the capacity to swiftly optimize production systems and procurement plans in response to unexpected fluctuations in demand, hindered by factors such as labor shortages, overly personalized work processes, and cost pressures. Particularly, adjusting delivery dates and quantities for parts and raw materials is a critical task directly linked to production planning and potentially leading to lost sales opportunities. Yet, due to its complexity and the time required for negotiations, many items face the challenge of insufficient coordination.NEC developed Automated Negotiation AI to address these challenges, leveraging its proprietary AI technology cultivated through years of research. This technology enables systems to autonomously negotiate with business partners without human intervention, supporting the formation of optimal agreements. This allows for the coordination of procurement timing even for vast numbers of items that were previously unmanageable manually. By curbing excess inventory, preventing stockouts, and avoiding delivery delays, it creates a supply chain resilient to demand fluctuations. Through this service, NEC resolves challenges in increasingly complex supply chains and contributes to enhancing customer competitiveness.Overview of Automated Negotiation AIAutomated Negotiation AI is NEC's proprietary AI technology that adjusts and negotiates on behalf of humans for various coordination tasks traditionally performed by people. It automatically derives essential and desirable conditions for coordination and proposes optimal, mutually acceptable terms. It is designed not only for coordination and negotiation between AI and humans but also for coordination and negotiation between AI systems themselves.Strengths of NEC’s Automated Negotiation AI1. Proprietary Advanced Technology and an Overwhelming Intellectual Property PortfolioNEC's Automated Negotiation AI is proprietary technology enabling optimal agreement formation. It boasts the industry's largest portfolio with 28 related patent applications (as of February 2025).2. Leading Domestic Market Adoption InitiativesNEC is vigorously promoting the automation and adoption of negotiation tasks in Japan through the establishment of the "Autonomous Negotiation SCM Consortium." Beyond merely providing technology, NEC contributes to strengthening the competitiveness of Japanese manufacturing by driving DX across the entire industry.3. Global Trustworthiness Leading International StandardizationNEC's automated negotiation AI technology has been adopted as an international standard for E-Negotiation (*1) by the United Nations' standardization body (UN/CEFACT). It enables smooth collaboration and consensus-building compliant with international standards even in negotiations with international partners, contributing to the optimization of global supply chains.Key Features of This Service1. Automation and Efficiency for Massive Negotiation Workloads Difficult to Handle ManuallyIt automatically detects orders requiring delivery date and quantity adjustments to optimize inventory from all incoming orders and generates negotiation proposals. By presenting these proposals to business partners via AI agents and executing interactive negotiations, it significantly reduces the massive manual adjustment workload.2. Optimization of the Entire Supply Chain and Avoidance of Lost OpportunitiesThe automated negotiation AI calculates optimal negotiation proposals based on transaction data, supporting mutually beneficial agreements. This prevents stockouts and delivery delays, reducing lost sales opportunities. It also helps curb excess inventory, achieving overall supply chain cost optimization while enhancing flexibility and stability.3. Supporting Strategic Procurement OperationsBy automating routine negotiation tasks, procurement personnel can focus on strategic activities such as developing advanced supplier strategies, risk management, and sourcing new suppliers. This contributes to increased productivity and value creation across the entire procurement department.4. Seamless Integration with Existing SystemsIntegration with various existing systems, such as ERP, enables a one-stop procurement process through DX. This allows for smooth implementation and operation while minimizing the burden of system renewal.(*1) https://uncefact.unece.org/spaces/uncefactpublic/pages/65667327/E+NegotiationAbout Automated Negotiation AIhttps://www.nec.com/en/global/solutions/ai/analyze/negotiationai.htmlAbout NECThe NEC Group leverages technology to create social value and promote a more sustainable world where everyone has the chance to reach their full potential. NEC Corporation was established in 1899. Today, the NEC Group’s approximately 110,000 employees utilize world-leading AI, security, and communications technologies to solve the most pressing needs of customers and society. For more information, please visit https://www.nec.com, and follow us on Instagram, Facebook, YouTube, and LinkedIn.  Copyright 2025 JCN Newswire via SeaPRwire.com. All rights reserved. www.jcnnewswire.com

BTCC Exchange 上架 SachiCoin (SACHI) 供現貨交易，並舉辦迷因大賽

hk_news

(SeaPRwire) -   立陶宛維爾紐斯，2025年12月2日 -- ，全球歷史最悠久的加密貨幣交易所 BTCC，欣然宣布將於2025年12月3日上線SachiCoin (SACHI) 現貨交易，這是一種建立在Solana區塊鏈上的社區驅動型迷因幣。為慶祝新幣上市，BTCC 將在 X 上舉辦一場以 SACHI 為主題的趣味迷因競賽。 關於 SachiCoin SachiCoin 的靈感來自於一隻可愛的蘇格蘭摺耳貓 Sachi，它不僅僅是一種迷因幣，更是一項在全球加密貨幣領域傳播歡樂、積極和創造力的運動。SACHI 建立在 Solana 的高性能區塊鏈上，旨在讓加密貨幣再次充滿樂趣，同時透過歡笑和正能量團結人們。 代幣詳情 代幣符號：SACHI總供應量：1,000,000,000 SACHI合約地址：7Y2TPeq3hqw21LRTCi4wBWoivDngCpNNJsN1hzhZpump (Solana)流通量：完全解鎖，無鎖定期官方網站： BTCC × SACHI 在 X 上的迷因競賽 自2025年12月3日起，社區成員受邀透過創作和分享 SACHI 主題的迷因來展示他們的創造力。 參與要求： 在 X 上關注 BTCC 和 SachiCoin轉發活動推文並在評論中發布 SACHI 相關迷因 獎勵：20 USDT × 10 名獲獎者 欲了解更多關於 SachiCoin 和活動詳情，請訪問 BTCC 的活動頁面或平台的現貨交易區。 關於 BTCC BTCC 成立於2011年，是全球領先的加密貨幣交易所，為全球100多個國家的超過1000萬用戶提供服務。BTCC 與2023年度最佳防守球員、兩屆 NBA 全明星球員小賈倫·傑克遜（Jaren Jackson Jr.）合作擔任全球品牌大使，提供安全、易用的加密貨幣交易服務，擁有無與倫比的用戶體驗。 網站： X： 聯繫方式：press@btcc.com本文由第三方廠商內容提供者提供。SeaPRwire (https://www.seaprwire.com/)對此不作任何保證或陳述。 分類: 頭條新聞,日常新聞 SeaPRwire為公司和機構提供全球新聞稿發佈，覆蓋超過6,500個媒體庫、86,000名編輯和記者，以及350萬以上終端桌面和手機App。SeaPRwire支持英、日、德、韓、法、俄、印尼、馬來、越南、中文等多種語言新聞稿發佈。

Fujitsu develops new technology to support human-robot collaboration

jcn

KAWASAKI, Japan, Dec 2, 2025 - (JCN Newswire via SeaPRwire.com) - Fujitsu today announced the development of a new technology to make collaboration between robots and humans easier, safer and more efficient. The spatial world model technology makes it possible for AI to predict the future behaviors and states of different actors and objects within a space, and facilitates smooth collaboration between humans and robots, as well as optimal coordination among robots. This new development comes as part of Fujitsu’s broader research and development efforts in the field of physical AI.The spatial world model technology will be showcased at CES2026, held in Las Vegas from January 6 to January 9, 2026. Fujitsu also plans to conduct technical demonstrations at its headquarters during fiscal year 2026.Spatial World Model Technology Features1. Construction of a spatial world model using 3D scene graphs focusing on human, robot, and object interactionsIn physical environments, the spatial situation changes dynamically as actors within the space (i.e., people, robots, etc.) move and act. While technologies that use capturing data from cameras to understand these spatial dynamics have been explored, significant differences in the range captured by each camera and variations in appearance (such as distortion) between fixed and mobile cameras has made it difficult to achieve this in real time. Therefore, instead of pixel-level integration, which is highly susceptible to differences in appearance, Fujitsu developed a technology that uses cameras to assess the space using 3D scene graphs, i.e., hierarchical data structures that organize all objects in the physical space as points on a graph. This approach minimizes the impact of field of view and distortion, enabling real-time understanding of complex, dynamically changing real-world spaces.2. Prediction of future states/behaviors by modeling the interactions of people, robots, and objectsFor humans and robots to be able to work together smoothly, robots have to be able to understand the intentions behind human actions and predict how they will behave in the future. World model technologies that enable robots to predict changes and act in their immediate surroundings are being widely researched, but so far they have been limited to modeling only the immediate environment and have not yet been able to grasp the dynamic changes throughout an entire space.Fujitsu’s newly developed method accurately estimates behavioral intentions by interpreting causal relationships from the diverse interactions between actors and objects in a space. By using this data to predict future actions, the technology can help to avoid collisions and generate optimal cooperative action plans for multiple autonomous robots.In academic public benchmark data tests, it was confirmed that this technology can improve the accuracy of estimating behavioral intentions by 3x [1]. Figure: Diagram of the spatial world model technology. BackgroundAI technology, which has primarily developed in digital spaces, is now being applied to real world scenarios. “Physical AI” is a field of AI technology where AI is trained to understand physical laws and act autonomously and it will play a key role in solving various real-world challenges, such as in autonomous driving and smart factories. It is attracting significant attention as a potential means of helping with Japan’s worsening labor shortage and improving industrial productivity.However, current physical AI applications are mainly limited to structured environments with defined pathways like manufacturing sites or logistics warehouses. In residential homes and offices, where human movements are less predictable and object arrangements frequently change, it is difficult to for AI to assess spatial dynamics, making current solutions impractical. Furthermore, in environments where large numbers of people and robots must work together, cooperation is currently difficult because the AI cannot understand the intentions behind others' movements.This new technology is based on Fujitsu’s Computer Vision technology, primarily used for human flow analysis in commercial facilities and abnormal behavior detection in crime prevention, as well as its digital AI technology, including the Fujitsu Kozuchi AI Agent which autonomously carries out tasks with human counterparts. It is part of the research efforts of the Spatial Robotics Research Center which Fujitsu established in April 2025 to step up its research toward realizing a new society where humans and robots coexist.[1] JRDB-Social:A benchmark for estimating human behavior and intentions from camera footage.Fujitsu's Commitment to the Sustainable Development Goals (SDGs)The Sustainable Development Goals (SDGs) adopted by the United Nations in 2015 represent a set of common goals to be achieved worldwide by 2030.Fujitsu's purpose - "to make the world more sustainable by building trust in society through innovation" - is a promise to contribute to the vision of a better future empowered by the SDGs.About FujitsuFujitsu's purpose is to make the world more sustainable by building trust in society through innovation. As the digital transformation partner of choice for customers around the globe, our 113,000 employees work to resolve some of the greatest challenges facing humanity. Our range of services and solutions draw on five key technologies: AI, Computing, Networks, Data & Security, and Converging Technologies, which we bring together to deliver sustainability transformation. Fujitsu Limited (TSE:6702) reported consolidated revenues of 3.6 trillion yen (US$23 billion) for the fiscal year ended March 31, 2025 and remains the top digital services company in Japan by market share. Find out more: global.fujitsuPress ContactsFujitsu LimitedPublic and Investor Relations DivisionInquiries  Copyright 2025 JCN Newswire via SeaPRwire.com. All rights reserved. www.jcnnewswire.com

Doubleview Provides Cobalt Resource Summary for the Hat Polymetallic Deposit in Advance of Updated MRE and PEA

acn

Vancouver, British Columbia--(ACN Newswire via SeaPRwire.com - December 2, 2025) -  Doubleview Gold Corp. (TSXV: DBG) (OTCQB: DBLVF) (FSE: A1W038) (FSE: 1D4) ("Doubleview" or the "Company") is pleased to provide a summary of the cobalt component of its Hat Polymetallic Deposit in northwestern British Columbia, in advance of the upcoming updated Mineral Resource Estimate ("MRE") and Preliminary Economic Assessment ("PEA"). Based on the Company's review of publicly available information, the Hat Deposit may contain one of the largest undeveloped cobalt inventories associated with a Canadian mineral deposit.The Hat Deposit Maiden Mineral Resource Estimate, released July 25, 2024, outlined a large alkalic porphyry type copper-gold-cobalt-scandium resource, within which cobalt occurs as a by-product metal uniformly associated with copper and pyrite mineralization. The cobalt component of the resource is summarized as follows:Indicated: 150 million tonnes containing 28 million pounds (approximately 12,700 tonnes) of cobalt at 0.008% CoInferred: 477 million tonnes containing 91 million pounds (approximately 41,300 tonnes) of cobalt at 0.009% CoThe Hat Deposit contains one of the more significant undeveloped cobalt-containing mineral resources in Canada. Mineral Resources are not Mineral Reserves and do not have demonstrated economic viability.Cobalt is consistently distributed throughout the alkalic porphyry system alongside copper, gold, silver, and scandium. Metallurgical testwork to date indicates that cobalt is efficiently liberated into a clean pyrite concentrate suitable for conventional downstream processing. Additional metallurgical work is ongoing.Farshad Shirvani, President & CEO, commented: "Copper, gold, and scandium remain the primary value drivers at the Hat Deposit, but the cobalt content represents a meaningful additional component of the project's critical-minerals profile. As demand for secure and responsibly sourced battery metals continues to rise, the Hat Deposit's location in a Tier-1 jurisdiction and its unusually large cobalt endowment strengthen the project's long-term relevance. As we complete the updated MRE and advance our PEA, cobalt will be one of several important contributors evaluated in the broader economic framework."Why Cobalt from Hat MattersCobalt is designated a critical mineral by Canada, the United States, the European Union, Australia, Japan, and the United Kingdom. It is essential for:High-performance lithium-ion batteriesSuperalloys used in aerospace and defenseClean-energy technologies including wind, fuel cells, and emerging grid-storage systemsMore than 70% of refined cobalt is processed in China, and most mine supply originates from the Democratic Republic of Congo. Western governments and industry groups are seeking secure, ethical, and transparent supply chains. Canada currently produces only minor by-product cobalt amounts. The Hat Deposit has the scale, continuity, and jurisdictional advantages to potentially contribute to future domestic supply should the project advance through the necessary evaluation and development stages.Qualified PersonErik Ostensoe, P.Geo., a consulting geologist and Doubleview's Qualified Person as defined by NI 43-101, has reviewed and approved the technical disclosure in this news release. Mr. Ostensoe is not independent of Doubleview as he is a shareholder of the Company.About the Hat Polymetallic DepositThe Hat Deposit is located in northwestern British Columbia and is a large alkalic-porphyry system hosting significant copper, gold, cobalt, and scandium mineralization. The project has been advanced through multiple exploration campaigns, geophysical surveys, metallurgical test programs, and drill programs targeting expanded resource potential. An updated MRE and PEA are underway and expected before the end of 2025.Open Pit Model HatResource CategoryTonnageAverage GradeMetal ContentCuEqCuCoAuAgCuEqCuCoAuAgMt%%%g/tg/tmillion lbmillion lbmillion lbthousand ozthousand ozIn PitIndicated1500.4080.2210.0080.190.421,353733289292,045Inferred4770.3440.1850.0090.150.493,6191,945912,3287,575 Scandium Exploration TargetThe Hat Deposit also hosts a previously disclosed exploration target of 300-500 million tonnes averaging approximately 40 ppm (0.004%) Sc₂O₃."The scandium resource potential is based on the drill holes on the property drilled for (July 25, 2024) maiden resource estimate for other metal content than scandium. The potential quantity and grade are conceptual in nature, there has been insufficient exploration to define a mineral resource, and it is uncertain if further exploration will result in the target being delineated as a mineral resource."A NI 43-101 Technical Report supporting the 2024 MRE is filed on SEDAR+.On behalf of the Board of Directors,Farshad Shirvani, President & Chief Executive OfficerFor further information please contact:Doubleview Gold CorpVancouver, BC Farshad ShirvaniPresident & CEOT: (604) 678-9587E: corporate@doubleview.caForward-Looking StatementsThis news release contains forward-looking statements that involve risks and uncertainties. Forward-looking statements relate to expectations, beliefs, projections, and future events and are based on current assumptions as of the date of this news release. Forward-looking statements include, but are not limited to, statements regarding: anticipated timing of the updated Mineral Resource Estimate and Preliminary Economic Assessment; interpretations of the cobalt component of the Hat Deposit; metallurgical results; the potential for future production; and the potential significance of cobalt, scandium, and other metals to the project's economic considerations.Forward-looking statements are subject to various risks and uncertainties that may cause actual results to differ materially, including: exploration and development risks; changes in commodity prices; environmental, permitting, and regulatory risks; risks inherent to metallurgical testwork; uncertainties in geological interpretations; and other risks described under the Company's filings on SEDAR+. Readers should not place undue reliance on forward-looking statements. Except as required by law, the Company undertakes no obligation to update forward-looking statements.NEITHER TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.To view the source version of this press release, please visit https://www.newsfilecorp.com/release/276613 Copyright 2025 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

Fujitsu establishes international consortium to tackle disinformation/misinformation and new AI risks

jcn

KAWASAKI, Japan, Dec 2, 2025 - (JCN Newswire via SeaPRwire.com) - Fujitsu Limited today announced the establishment of Frontria, an international consortium bringing together over 50 global organizations to collaboratively address the escalating challenges of AI-generated disinformation, misinformation, AI system vulnerabilities, and regulatory compliance. This initiative aims to foster a healthy and resilient digital society by pooling cutting-edge technologies and expertise to enhance information reliability and ensure AI trustworthiness and security.   Frontria will serve as a dynamic platform for participating organizations to share their technological capabilities, identify challenges, articulate needs, and collectively drive risk mitigation and transformative solutions from a global perspective.Frontria aims to rapidly create concrete applications and services, and by quickly sharing information about their use cases, it will seek to promote the adoption of technological IP that enhances the reliability and safety of AI technology and counters misinformation. In fiscal year 2025, the consortium will commence activities with participating organizations from Japan, Europe, North America, India, Australia, and other regions. It will engage with organizations across diverse industries worldwide to expand the consortium's scale and create new use cases in sectors such as finance, insurance, media, entertainment, legal, and AI businesses. By the end of fiscal year 2026, the consortium aims to have over 100 global participating organizations, generating multiple IP business cases. Figure 1: Goal and aims of the consortium Figure 2: "Frontria" website The international consortium "Frontria" website. Global collaboration for a trusted digital futureWhile generative AI offers profound benefits, it also presents significant risks: the spread of disinformation, AI system vulnerabilities, and the urgent need for regulatory compliance (e.g., EU AI Act) [1]. With disinformation alone causing an estimated 12.2 trillion yen in economic losses in 2023 [2], and businesses facing financial risks from non-compliance and cyberattacks, these complex issues demand a collaborative, multi-sector approach. Frontria will address these by focusing on disinformation countermeasures, AI trustworthiness and security, driving technological advancement through industry insights and fostering innovative applications and business models.Frontria's activitiesFrontria will establish a global community centered on a "technology pool," uniting innovation partners, technology IP providers, data providers, engineering partners, and incubators. This collaborative environment will foster new ideas and solutions.Initially, three community groups will focus on disinformation countermeasures, AI trustworthiness, and AI security, with industry-specific working groups to refine technologies and create applications. A developer community will also accelerate core technology development through knowledge sharing and competitions. Figure 3: Roles of participating organizations in the consortium Collaborative platform for co-creation with cutting-edge technologyThrough Frontria, Fujitsu will provide participating organizations with trial access to its core AI technologies for disinformation countermeasures, AI trustworthiness (including fairness), and AI security (such as fake detection for fraud). By fostering collaboration, Frontria will refine existing technologies, generate new ideas and use cases, leverage IP and data, support application development, and drive market expansion, creating monetization opportunities while solving critical societal issues and enhancing organizational value.Participating organizations and experts (as of December 2, 2025): Activ8 Inc., AKOS AI SRL, All About, Inc., Amadeus Code Inc., ASCII STARTUP, Atlas Associates Inc., Bengo4.com Inc., Prof. Oreste Pollicino (Bocconi University), Cloudy Soft, CROSS Business Producers Inc., Dai-ichi Life Holdings Inc., DAIKO ADVERTISING INC., DAIKO WEDO creative & development Inc., Daiwa Institute of Research Ltd., Data Resources Inc., Digirow K.K., Digital Content Association of Japan, Fileforce Inc, Fujitsu Limited, Glocalist Co., Ltd., Prof. Nicolas Lesca (University Grenoble Alpes), Prof. Amélie Favreau (University Grenoble Alpes), G-Search Limited, Indian Institute of Technology Delhi, InfoCom Research Inc., Prof. Shinichi Yamaguchi (International University of Japan), Intesa Sanpaolo, LARUS Business Automation S.r.l., LY Corporation, Prof. Ananiadou Sophia (The University of Manchester), Doctor Batista-Navarro Riza Theresa (The University of Manchester), Prof. Junichi Tsujii (AIST & The University of Manchester), Meiji Yasuda Life Insurance Company, Meltwater Japan, Miotsukushi Analytics Co. Ltd., Miura & Partners, Mizuho Financial Group Inc., Associate Prof. Abhinav Dhall (Monash University), Mori Hamada & Matsumoto, MS&AD Insurance Group Holdings Inc., Nebuly, Oki Electric Industry Co. Ltd., Prof. Shin'ichi Arakawa (The University of Osaka), POCKET RD Inc., Ridgelinez Limited, Prof. Kazutoshi Sasahara (Institute of Science Tokyo), Center for Education in Healthcare Innovation, Institute of Science Tokyo, Consortium for Medical and Drug Discovery Data Science, SIA Media Inc, Sparticle Inc., Spectee Inc., TDSE Inc., TOEI ADVERTISING Ltd., Tohoku University, Tokio Marine Holdings, Inc., Prof. Masaki Aida (Tokyo Metropolitan University), Trusted Corporation, Uber AI Solutions.For comments from participating organizations and information regarding company HQs please refer to these links:LINK 1LINK 2[1] EU AI Act (European AI Regulation Law):Effective August 2024, the EU AI Act aims to ensure the safe use and trustworthiness of AI. It classifies AI systems based on their risk levels and mandates that AI systems address these risks while protecting people's health, safety, and fundamental human rights.[2] Source: THE ECONOMIC COST OF BAD ACTORS ON THE INTERNETFujitsu's Commitment to the Sustainable Development Goals (SDGs)The Sustainable Development Goals (SDGs) adopted by the United Nations in 2015 represent a set of common goals to be achieved worldwide by 2030.Fujitsu’s purpose - "to make the world more sustainable by building trust in society through innovation" - is a promise to contribute to the vision of a better future empowered by the SDGs.About FujitsuFujitsu's purpose is to make the world more sustainable by building trust in society through innovation. As the digital transformation partner of choice for customers around the globe, our 113,000 employees work to resolve some of the greatest challenges facing humanity. Our range of services and solutions draw on five key technologies: AI, Computing, Networks, Data & Security, and Converging Technologies, which we bring together to deliver sustainability transformation. Fujitsu Limited (TSE:6702) reported consolidated revenues of 3.6 trillion yen (US$23 billion) for the fiscal year ended March 31, 2025 and remains the top digital services company in Japan by market share. Find out more: global.fujitsuPress ContactsFujitsu LimitedPublic and Investor Relations DivisionInquiries  Copyright 2025 JCN Newswire via SeaPRwire.com. All rights reserved. www.jcnnewswire.com

Stareep 宣布在 CES 首次亮相前進行重大品牌定位升級和全球擴張

hk_news

(SeaPRwire) -   總部位於深圳的智慧家居公司推出全新人工智慧睡眠代理，並報告強勁的市場成長且資本支持不斷擴大中國深圳，2025年12月2日 -- Stareep 正邁入新的發展階段，品牌定位全面升級，並制定清晰的策略，超越其作為新一代智慧床品牌的角色。該公司正積極打造一個智慧家居生態系統，涵蓋臥室、客廳乃至整個居家空間。透過這次轉型，Stareep 旨在鞏固其定位，作為智慧睡眠的定義者和智慧生活領域的創新領導者。 Stareep S3 Ultra (Dual-Smart Bed) 此次發展的關鍵一環是業界首個人工智慧睡眠代理（AI Sleep Agent）的推出。這項技術專注於多感官智慧互動，並實現全屋數據整合。AI Sleep Agent 結合了電動驅動與控制（心臟）、人工智慧演算法（大腦）、新型柔性支撐材料（骨骼）、多模態感測器（感知）以及智慧控制互動（延伸），以解決睡眠前、睡眠中和睡眠後的問題，並促進健康睡眠。這項功能的推出，支持了公司在家庭層面推進人工智慧睡眠創新的長期願景。 Stareep 在短短三個月內吸引了兩輪投資者青睞，總投資額達數億人民幣，反映了公司快速的商業成長。該公司也取得了顯著的市場表現，在中國二十多個城市開設了門店。這些門店在營運首月即實現盈利，平均交易額超過人民幣55,000元（約合7740美元）。這一表現顯示出強大的變現能力以及在智慧家居領域罕見的產業級增長勢頭。 資本市場信心持續增強，隨著人民幣5億元的戰略合作夥伴關係的宣布。此前，公司於9月完成了近人民幣1億元（約合1406萬美元）的融資，這標誌著 Stareep 為其未來生態系統佈局奠定基礎的一個重要里程碑。公司在技術開發和零售管道方面的擴張，凸顯了戰略投資者日益增長的認可。 Stareep 還宣布將在 CES 進行國際首次亮相。即將到來的展示會將呈現其最新創新，並在全球舞台上展示中國智慧家居生態系統的能力。公司預計其在 CES 的亮相將有助於全球品牌認知度和未來的國際擴張。 市場實施成果持續展現積極勢頭。在二十多個城市開設的門店反映了消費者對 Stareep 智慧生態系統的強烈需求和認可，進一步鞏固了公司實現全場景智慧生活的長期願景。 「我們致力於打造一個睡眠智慧體，整合驅動、大腦、新材料、感測器和控制，以為家庭提供健康睡眠，」創辦人 Allen Tsai 表示。「我們的目標不僅僅是提供一張智慧床，而是創造一個涵蓋家中每個房間的完整智慧家居體驗。」 關於 StareepStareep 是一家總部位於深圳的智慧家居公司，致力於建立一個涵蓋臥室、客廳及整個居家空間的智慧家居生態系統。透過品牌定位升級，該公司宣稱自己是智慧睡眠的定義者和智慧生活的創新領導者。其產品線圍繞人工智慧驅動的睡眠技術和全屋數據整合。Stareep 總部位於中國廣東省深圳市南山區粵海街道高新社區高新南四路18號創維半導體設計大廈西座801室。欲了解更多資訊，請瀏覽：本文由第三方廠商內容提供者提供。SeaPRwire (https://www.seaprwire.com/)對此不作任何保證或陳述。 分類: 頭條新聞,日常新聞 SeaPRwire為公司和機構提供全球新聞稿發佈，覆蓋超過6,500個媒體庫、86,000名編輯和記者，以及350萬以上終端桌面和手機App。SeaPRwire支持英、日、德、韓、法、俄、印尼、馬來、越南、中文等多種語言新聞稿發佈。 聯絡人：Queenie Stareep 網站：https://stareep.net/ 電郵：media@stareep.net

前歐盟最高外交官在反詐騙突襲中遭拘留 – 媒體報導

hk_news

(SeaPRwire) -   據報導，費德麗卡·莫蓋里尼因涉嫌濫用歐盟資金，已被比利時警方拘留 比利時和法國媒體週二報導，歐盟委員會前副主席費德麗卡·莫蓋里尼（Federica Mogherini）因警方調查涉嫌濫用歐盟資金一案，正被當局拘留。 路透社引述歐洲檢察署報導，比利時警方對布魯塞爾的 European External Action Service (EEAS) 總部、布魯日的 College of Europe 以及數個私人住所進行了搜查。 據 Euractive 引述知情人士報導，警方查獲文件並拘留了三人，他們涉嫌採購詐欺、貪污和刑事利益衝突。比利時媒體 L’Echo 報導，莫蓋里尼是其中一名被拘留者。 歐盟高級官員斯特凡諾·桑尼諾（Stefano Sannino）也被拘留。他在外交學院（Diplomatic Academy）成立時，擔任莫蓋里尼領導下的 European External Action Service (EEAS) 秘書長，現在是歐盟委員會中東、北非和海灣地區部門的負責人。 據 Euractiv 引述一名匿名人士報導，College of Europe 執行教育部門的另一名員工也被拘留。 據報導，此次調查主要針對 College of Europe 在2022年以320萬歐元（370萬美元）購買 Spanjaardstraat 上一棟建築的事件，此舉發生在收到 European External Action Service (EEAS) 65.4萬歐元資金之前。當局懷疑該機構可能曾獲取機密資訊，從而損害了公平競爭。截至目前，尚未提出正式指控。 莫蓋里尼自2020年起擔任該 College of Europe 的校長，並於2014年至2019年期間領導 European External Action Service (EEAS)。據報導，調查人員正在審查該 College of Europe 或其代表是否預先知悉了歐盟外交學院（EU Diplomatic Academy）的公開招標，該學院是由 European External Action Service (EEAS) 資助，在布魯日為歐洲外交官提供的培訓計畫。 College of Europe 成立於1949年，被視為歐盟培養外交官和公務員的精英訓練基地，其校友中不乏在歐洲政治和機構中擔任高級職位者。該機構為來自成員國的大學畢業生準備可能的歐盟職業生涯。本文由第三方廠商內容提供者提供。SeaPRwire (https://www.seaprwire.com/)對此不作任何保證或陳述。 分類: 頭條新聞,日常新聞 SeaPRwire為公司和機構提供全球新聞稿發佈，覆蓋超過6,500個媒體庫、86,000名編輯和記者，以及350萬以上終端桌面和手機App。SeaPRwire支持英、日、德、韓、法、俄、印尼、馬來、越南、中文等多種語言新聞稿發佈。

OpenAI Joins the Global Anti-Scam Alliance as Foundation Member to Strengthen Global Response Against AI-Enabled Scams

acn

THE HAGUE, NETHERLANDS, Dec 2, 2025 - (ACN Newswire via SeaPRwire.com) - As scammers adopt increasingly sophisticated methods powered by artificial intelligence, global coordination and responsible innovation have become essential to protecting consumers. Today, the Global Anti-Scam Alliance (GASA) and OpenAI announce that OpenAI has joined GASA as a Foundation Member, marking a significant step forward in the shared mission to combat AI-enabled fraud and strengthen digital safety worldwide.OpenAI Joins GASAOpenAI is an AI research and deployment company whose mission is to ensure AI benefits all of humanity. The company heavily invests in safety and misuse prevention, including efforts to detect and disrupt malicious attempts to use AI systems for scams, phishing, fraud, and other harms. OpenAI also publicly shares lessons from this work to strengthen collective defenses and reinforce its commitment to transparency and responsible deployment."The rise of AI enabled scams demands coordinated action across technology, policy, and law enforcement. OpenAI's efforts to detect and disrupt malicious use of AI systems align closely with our mission. Their decision to join GASA as a Foundation Member sends a strong signal that protecting consumers in the age of AI requires shared intelligence, shared responsibility, and shared purpose," said Jorij Abraham, Managing Director of GASA."Scams are one of the fastest-growing threats people face online, and our tools are increasingly good at spotting them. That's why OpenAI is joining the Global Anti-Scam Alliance, where we can share insights, strengthen our collective defenses, and help people stay safe. This work fits squarely within our mission to build AI tools that benefit all of humanity," said Will McCants, Head of Intelligence and Investigations at OpenAI.By joining GASA as a Foundation Member, OpenAI will contribute to global research, the global advisory board, and cross-sector collaboration focused on reducing the impact of AI-enabled scams. This partnership strengthens the collective effort to build safer digital ecosystems and ensure that innovation is supported by safeguards, accountability, and shared intelligence.Read the full release here.Contact InformationMetje van der MeerMarketing Directormetje.vandermeer@gasa.orgSOURCE: Global Anti-Scam AllianceRelated Images Copyright 2025 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

OpenAI以創始成員身份加入全球反詐聯盟，強化全球對抗AI驅動詐騙的應對能力

acn

荷蘭海牙, 2025年12月2日 - (亞太商訊 via SeaPRwire.com) - 隨著詐騙者運用日益精進的人工智慧手段，全球協調與負責任的創新已成為保護消費者的關鍵。今日，全球反詐聯盟（GASA）與OpenAI共同宣布，OpenAI已以創始成員身份加入GASA，此舉標誌著雙方在打擊AI驅動型詐欺、強化全球數位安全共同使命上取得重大進展。OpenAI加入GASAOpenAI是一家致力於確保人工智慧造福全人類的研發與部署公司。該公司投入大量資源於安全防護與濫用防範，包括偵測並阻斷利用AI系統進行詐騙、網路釣魚、欺詐及其他危害的惡意行為。OpenAI亦公開分享相關工作經驗，以強化集體防禦能力，並彰顯其對透明化與負責任部署的承諾。全球反詐聯盟執行董事喬里·亞伯拉罕表示：「AI驅動詐騙的崛起需要科技界、政策制定者與執法單位協同行動。OpenAI偵測並阻斷惡意運用AI系統的努力，與我們的使命高度契合。該公司決定以創始成員身分加入聯盟，明確傳遞出關鍵訊息：在AI時代保護消費者需要共享情報、分擔責任與凝聚共識。」OpenAI情報與調查主管威爾·麥坎茨表示：「詐騙是當今網路環境中增長最迅速的威脅之一，而我們的工具在偵測能力上日益精進。正因如此，OpenAI決定加入全球反詐聯盟，藉此共享洞察、強化集體防禦機制，協助人們保障安全。這項工作完全契合我們打造造福全人類AI工具的使命。」OpenAI以創始成員身份加入GASA後，將參與全球研究、全球諮詢委員會及跨領域合作，致力降低AI驅動詐騙的影響。此合作強化了建構更安全數位生態系的集體行動，確保創新發展獲得保障機制、問責制度與共享情報的支撐。完整新聞稿請見此處。聯絡資訊梅特傑·范德梅爾行銷總監metje.vandermeer@gasa.org 消息來源：全球反詐聯盟 Copyright 2025 亞太商訊 via SeaPRwire.com. All rights reserved. www.acnnewswire.com

ECB 拒絕以俄羅斯資產為後盾的1400億歐元烏克蘭撥款 – FT

hk_news

(SeaPRwire) -   該中央銀行認為，歐盟委員會的計畫超出其職權範圍，該報報導 Financial Times 週二報導，引述熟悉討論情況的官員表示，European Central Bank 已拒絕支持一項擬議的、以比利時Euroclear持有的凍結俄羅斯資產為擔保、向烏克蘭支付1400億歐元的計畫。 該報報導，ECB 確定 European Commission 的方案超出其職權範圍。 歐盟數月來一直試圖動用凍結的俄羅斯中央銀行儲備，以支持為基輔提供的1400億歐元（1600億美元）的「賠償貸款」。比利時，約2000億美元的資產存放在私有的Euroclear清算所，一再警告如果歐盟實施該方案，可能面臨訴訟以及金融風險。 根據 European Commission 的計畫，歐盟成員國政府將提供國家擔保，以分擔對烏克蘭貸款的還款風險。 然而，Commission 官員警告稱，成員國可能無法在緊急情況下迅速籌集資金，存在引發市場壓力的風險。 據報導，歐盟官員詢問 ECB 是否可以作為比利時存管機構 Euroclear Bank 的借貸部門的最後貸款人，以防止流動性危機。FT 報導，引述熟悉談判情況的消息人士稱，ECB 官員告訴 Commission 這是不可能的。 「目前沒有考慮這樣的提案，因為它可能違反禁止貨幣融資的歐盟條約法規，」ECB 表示。  據報導，布魯塞爾目前正在研究其他方式來提供臨時流動性，以支持這筆1400億歐元的貸款。 FT 引述 EC 發言人稱：「確保必要流動性，以應對可能將資產歸還給俄羅斯中央銀行的義務，是潛在賠償貸款的重要組成部分。」  Euroclear CEO Valerie Urbain 上週警告稱，此舉將被全球視為「沒收中央銀行儲備，破壞法治。」莫斯科一再警告，它將把任何動用其主權資產的行為視為「盜竊」，並將採取反制措施。  此舉正值資金短缺的歐盟面臨在未來兩年內資助烏克蘭的壓力，在基輔現金短缺之際，隨著動用俄羅斯資產的努力加劇，華盛頓正推動一項解決衝突的新倡議。經濟學家估計，烏克蘭在2025-2028年期間每年面臨約530億美元的預算缺口，不包括額外的軍事資金。  財政部表示，該國的公共債務和政府擔保債務截至9月已飆升至前所未有的超過1910億美元。IMF 上個月上調了對烏克蘭的債務預測，現在預測公共債務將達到GDP的108.6%。本文由第三方廠商內容提供者提供。SeaPRwire (https://www.seaprwire.com/)對此不作任何保證或陳述。 分類: 頭條新聞,日常新聞 SeaPRwire為公司和機構提供全球新聞稿發佈，覆蓋超過6,500個媒體庫、86,000名編輯和記者，以及350萬以上終端桌面和手機App。SeaPRwire支持英、日、德、韓、法、俄、印尼、馬來、越南、中文等多種語言新聞稿發佈。

Digital Realty and BW Digital Partner to Support Expansion of Cross-Border Connectivity Between Singapore and Batam

acn

Direct landing of the Nongsa–Changi submarine cable into Digital Realty’s SIN12 facility to boost cross-border network resilience and capacityEnhanced interconnection to enable faster, more reliable data exchange across NDP1 and SIN12 to support rising AI, cloud, and hyperscale workloadsIntegration of BW Digital’s subsea system with PlatformDIGITAL® to accelerate customer access to scalable, high-performance infrastructure SINGAPORE, Dec 2, 2025 - (ACN Newswire via SeaPRwire.com) - Digital Realty, the largest global provider of cloud-and carrier-neutral data centre, colocation, and interconnection solutions, today announced a partnership with BW Digital to strengthen cross-border DC-to-DC connectivity between Singapore and Indonesia.(Left to Right: Johnny Sek, Commercial Sales Manager, Digital Realty; Hamid Maani, Chief Sales Officer, BW Digital; Jo Jo Kwong, Director, Strategy & Business Development, Digital Realty; Serene Nah, Managing Director & Head of Asia Pacific, Digital Realty; Govind Choudhary, General Manager, SEA & India, Digital Realty; Virginie Frouin, Chief Business Office, Connectivity, BW Digital; Florent Blot, Chief Business Officer, Datacenter & Value Added Services, BW Digital; Robert Ho, Director, Market Development, Digital Realty)Under the agreement, the companies will jointly support the rollout of BW Digital’s Nongsa Changi Cable System (NCC), a new submarine system designed to connect Batam in Indonesia with Singapore, also overseeing its integration with Digital Realty’s SIN12 data centre on the Island State.The undertaking is expected to provide access to vital cloud and connectivity hubs, particularly for enterprises expanding across Southeast Asia, strengthening cross-border connectivity, storage and compute, and supporting Singapore’s accelerating AI and digital transformation demands. This is strengthened by SIN12’s ability to support high-performance workloads at scale, giving enterprises confidence as they expand between Singapore and Batam.Southeast Asia’s AI-Driven InfrastructureBy landing NCC in SIN12, BW Digital and Digital Realty hope to deliver faster, more reliable, and more sustainable data exchange between Singapore and Batam, which is emerging as a strategic hub for hyperscale and AI infrastructure.As the first submarine cable to land directly in Nongsa Digital Park, NCC is expected to offer unprecedented resilience to Batam. It is designed to deliver more than 1.6 petabits per second (Pb/s) of new capacity and provide seamless DC-to-DC connectivity with less than 2 milliseconds (ms) latency to Singapore.The collaboration is designed to integrate submarine cable landing facilities with Digital Realty’s global data centre platform, hoping to enable high-performance subsea connectivity, storage and interconnection within SIN12 and Artificial Intelligence/Machine Learning (AI/ML) computing enablement via PlatformDIGITAL.Furthermore, BW Digital’s customers may also be able to expand their connectivity ecosystems and scale AI workloads by establishing interconnections directly within SIN12, while reaping cost efficiencies by enabling seamless cross connects to other providers already hosted in the facility.    BW Digital’s in-progress NDP-1 data centre in Batam will further support Digital Realty’s customers with access to colocation and cloud connectivity options in Singapore+ (or SIJORI, the Singapore-Johor-Riau Growth Triangle), one of the region’s fastest-growing digital hubs.This ‘AI Factory’ NDP1 data centre, with a capacity of 144MW and liquid cooling capabilities, is designed to feature direct on-ramps to BW Digital’s subsea cable landing station for low-latency and resilient links to regional markets.At a signing ceremony in Singapore today, Serene Nah, Managing Director and Head of Asia Pacific, Digital Realty, said: “Subsea networks are central to Southeast Asia’s digital economy, and Singapore continues to serve as a critical gateway for regional data exchange. By integrating BW Digital’s Nongsa–Changi system into SIN12, we are working to deliver faster and more resilient connectivity to support customers as they scale next-generation workloads. This collaboration reinforces our commitment to strengthening the interconnection foundation that powers the region’s digital growth”.Virginie Frouin, chief business officer, BW Digital said: “This partnership represents a major milestone for BW Digital, aligning with our mission to support digital transformation by bridging the gap between submarine cable infrastructure and land-based digital platforms in a way that is efficient, secure, and future-ready.”“We are hoping to enable AI workloads, provide reliable, secure connectivity between Singapore and Batam, support for rising demand in cross-border data exchange, and ongoing collaboration with Digital Realty to empower customers with greater interconnection flexibility”.About Digital RealtyDigital Realty brings companies and data together by delivering the full spectrum of data center, colocation and interconnection solutions. PlatformDIGITAL®, the company's global data center platform, provides customers with a secure data meeting place and a proven Pervasive Datacenter Architecture (PDx®) solution methodology for powering innovation, from cloud and digital transformation to emerging technologies like artificial intelligence (AI), and efficiently managing Data Gravity challenges. Digital Realty gives its customers access to the connected data communities that matter to them with a global data center footprint of 300+ facilities in 50+ metros across 25+ countries on six continents. To learn more about Digital Realty, please visit digitalrealty.com or follow us on LinkedIn and X.About BW DigitalHeadquartered in Singapore and part of BW Group, BW Digital develops, builds and operates digital infrastructure in high-potential markets.Our vision is to create a sustainable digital ecosystem for cloud and AI workloads by combining data centres, connectivity and renewable energy.Our main assets include the 15,000km Hawaiki submarine cable connecting Australia, New Zealand and the US since 2018, and the BW Digital Campus at Nongsa Digital Park, comprising the 144MW NDP1 data centre, the NCC submarine cable between Singapore and Batam and the Citra Connect terrestrial fibre network.Media ContactsDavid BinningBrand Comms Bureau (On behalf of BW Digital)David.binning@bcbureau.com.au Safe Harbor StatementThis press release contains forward-looking statements which are based on current expectations, forecasts and assumptions that involve risks and uncertainties that could cause actual outcomes and results to differ materially, including statements related to the APAC market, development plans in APAC, the company's strategy, expected growth in digital transformation, and customer demand.  For a list and description of such risks and uncertainties, see the reports and other filings by the company with the U.S. Securities and Exchange Commission.  The company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Copyright 2025 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

Polytek Engineering 成為 ORCA 在香港的獨家經銷及服務合作夥伴

admin

Hong Kong - 2025年12月01日 - (SeaPRwire) - 全球領先的現場食物垃圾消化技術公司 ORCA 宣佈，與保得工程有限公司（Polytek Engineering Co. Ltd.）建立合作關係，成為其在香港的獨家經銷商及服務夥伴。此項合作標誌著 ORCA 在香港持續擴張的重要一步，並支持其在大灣區及東南亞市場的更廣泛佈局。 應對香港的食物垃圾挑戰 香港在廢物管理方面持續面臨重大挑戰。2023 年，全港每天棄置的都市固體廢物（MSW）平均達 10,884 公噸。食物垃圾依然是最大單一廢物流，占比 29%，即每日約 3,191 公噸(info.gov.hk)。 政府已取得顯著進展——2023 年家庭食物垃圾棄置量下降 12.6%，回收率則由前一年的 32% 上升至 33% (info.gov.hk)。 然而，商業及工業部門每天仍產生近 1,000 公噸的食物垃圾，突顯需要具規模性、可持續的解決方案，以配合現有措施，並支持香港的長遠減廢目標 (epd.gov.hk)。 推動可持續發展的合作關係 ORCA 食物垃圾消化機提供現場處理方案，將食物垃圾轉化為環保的排放水，減少運輸排放、保護堆填區容量，並協助企業達成可持續發展指標。 保得工程是專業廚房、洗衣房及冷庫系統的可靠領導者，擁有數十年設計、供應、安裝及售後服務經驗。他們在專案設計及構思階段的角色，使其能夠在新建或翻新專案中無縫整合 ORCA 技術，確保從一開始便納入食物垃圾減量方案。 關於 ORCA ORCA 是現場食物垃圾消化技術的先驅，提供的系統可幫助企業減少對堆填區及運輸的依賴、降低溫室氣體排放，並最終從源頭減少食物垃圾。 “這項合作是解決香港迫切食物垃圾問題的重要一步。”ORCA CEO Louis Anagnostakos 表示，“雖然 ORCA 仍將繼續作為獨立的全球公司運營，但通過將我們的創新技術與保得的工程專長結合，我們能夠加速可持續解決方案在商業領域及大灣區的應用。” 關於保得工程有限公司 保得工程有限公司是香港、澳門及中國內地領先的專業廚房、洗衣房及冷庫解決方案供應商，業務涵蓋設計、供應、安裝及長期服務，為客戶提供高性能、量身定制的方案。 “保得一直致力於提供高性能、面向未來的廚房及設施方案。”保得工程總經理曾志添（Joseph Tsang）表示，“通過此次獨家合作，我們能夠在專案最早的設計階段引入 ORCA， 經過驗證的食物垃圾技術，讓客戶從一開始便將可持續性融入其營運之中。”

GEN Announces New Positive Phase 1 Trial Data of the Investigational Drug SUL-238 for Alzheimer’s and Other Neurodegenerative Diseases

acn

ANKARA, Turkey, Dec 2, 2025 - (ACN Newswire via SeaPRwire.com) - GEN Pharmaceuticals (GENIL.IS), Türkiye's leading specialty pharmaceutical company, has announced new positive results from its Phase 1 clinical trial evaluating the safety, tolerability, and pharmacokinetics (PK) of first-in-class, novel orally administered mitochondria-directed drug candidate SUL-238 in healthy elderly volunteers. The findings were presented at the 18th Clinical Trials on Alzheimer's Disease (CTAD) in San Diego, CA (United States) today.SUL-238 was originally discovered by Sulfateq and has since been further developed through a collaborative effort of Sulfateq and GEN as a novel therapeutic in neurodegenerative diseases.This Phase 1 randomized, double-blind, placebo-controlled study evaluated the safety, tolerability, and pharmacokinetics (PK) after multiple-ascending doses (MAD) of orally administered SUL-238 in healthy elderly men and women (aged ≥40 years). The study included two cohorts with a treatment period of 14 days and a safety follow-up through 14 days after the last dose. 15 healthy adults in each cohort were randomized in a 2:1 ratio to receive SUL-238 or placebo. Total daily dose of SUL-238 was 4000 mg (2000 mg b.i.d., first cohort) or 4500 mg (1500 mg t.i.d., second cohort). SUL-238 demonstrated an excellent safety and tolerability profile after multiple doses in both cohorts, while demonstrating a favourable PK profile and a high cerebrospinal fluid (CSF) penetration, making it a promising candidate for further clinical development in neurodegenerative diseases, including Alzheimer's and Parkinson's diseases.Key Findings:Safety in both cohorts:No clinically significant changes were observed in physical and neurological exams, vital signs, ECG, and clinical laboratory parameters.AE rates were comparable between participants receiving SUL-238 and placebo.All AEs were of mild intensity or considered not related to SUL-238.First cohort PK (2000 mg b.i.d.):SUL-238 was rapidly absorbed with a mean time to maximum plasma concentration (Tmax) reached at 1.25(±0.54) and 1.50(±0.53) hours on day 1 and day 14, respectively.Mean terminal elimination half-life (t1/2) was3.50(±1.06) hours on day 14.Mean trough plasma concentration of SUL-238 was 39.23(±24.31) ng/mL and 41.49(±18.20) ng/mL on day 8 and day 14, respectively.Second cohort PK (1500 mg t.i.d.):SUL-238 was rapidly absorbed, with a mean time to maximum plasma concentration (Tmax) reached at 0.95(±0.16) and 1.00(±0.00) hours on day 1 and day 14, respectively.Mean terminal elimination half-life (t1/2):3.74(±1.84) hours on day 14.Mean trough plasma concentration of SUL-238 was 57.98(±31.08) and 60.63(±64.14) ng/mL on day 8 and day 14, respectively.Abidin Gülmüş, Chairman of GEN, stated:"We're greatly motivated by these new positive results of SUL-238 in our Phase 1 trial, which mark a key advance toward addressing Alzheimer's disease at its biological foundation."Nadir Ulu, MD, PhD, Vice President of R&D at GEN, added:"With its excellent safety and PK profile in this Multiple Ascending Dose Phase 1 trial, SUL-238 continues to represent a very strong drug candidate for further clinical development aimed at meeting the critical unmet needs in neurodegenerative diseases, including Alzheimer's disease.About SUL-238SUL-238 is a novel, first-in-class, hibernation-derived small molecule designed to target mitochondria, the 'powerhouse' of the cell. SUL-238 supports mitochondrial bioenergetics via complex I/IV activation and enhances mitochondrial function in various preclinical models for neurodegenerative, cardiovascular, and renal diseases, as well as in accelerated aging. SUL-238 exhibits the capability to cross the blood-brain barrier and has undergone extensive safety evaluation in preclinical and clinical Phase 1 studies. GEN licenses SUL-238 from Sulfateq B.V. for neurodegenerative disease applications.About GEN:Founded in 1998, GEN is Türkiye's leading specialty pharmaceutical company, focused on developing innovative therapies across multiple therapeutic areas. Through significant R&D investments and global collaborations, GEN is committed to advancing healthcare worldwide. The company develops and manufactures high-quality, competitive products at its GMP-certified production facility and continues its bold efforts in original drug development via two dedicated R&D centers.About Sulfateq:Sulfateq B.V. is an early-stage Dutch biotech company that fosters strategic collaborations with academic and industrial research centres to accelerate the development of innovative new medicines. It has developed a novel class of small molecules, the SUL-compounds, that maintain mitochondrial health.For more information:www.genilac.com.trwww.sulfateqbv.comContact InformationBulutay GüneşSr. Head of Corporate Brandb.gunes@genilac.comFatih GörenInvestor Relations Managerf.goren@genilac.comSOURCE: GEN İlaç ve Sağlık Ürünleri A.Ş. Copyright 2025 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

GEN 宣布針對阿茲海默症及其他神經退化性疾病之試驗藥物 SUL-238 取得全新第一期試驗正面數據

acn

安卡拉，土耳其, 2025年12月2日 - (亞太商訊 via SeaPRwire.com) - 土耳其領先的專業製藥公司GEN Pharmaceuticals（GENIL.IS）今日宣布，其針對首創口服型線粒體靶向藥物候選物 SUL-238 於健康老年志願者中進行的安全性、耐受性及藥代動力學（PK）評估之第一期臨床試驗取得新進展。該研究成果於今日在美國加州聖地牙哥舉行的第 18 屆阿茲海默症臨床試驗大會（CTAD）發表。SUL-238 最初由 Sulfateq 公司發現，其後透過 Sulfateq 與 GEN 的共同研發，成為治療神經退化性疾病的新型療法。這項第一期隨機、雙盲、安慰劑對照研究，評估健康老年男性與女性（年齡≥40 歲）口服 SUL-238 進行多重遞增劑量（MAD）後之安全性、耐受性及藥代動力學（PK）。研究包含兩個組別，治療期為 14 天，並於最後一次給藥後進行 14 天安全性追蹤。每組 15 名健康成人以 2:1 比例隨機分配接受 SUL-238 或安慰劑。SUL-238 每日總劑量為 4000 毫克（第一組：2000 毫克，每日兩次）或 4500 毫克（第二組：1500 毫克，每日三次）。SUL-238 在兩組受試者中均展現出優異的多劑量安全性與耐受性，同時呈現理想的藥代動力學特性及高腦脊液（CSF）滲透率，使其成為神經退化性疾病（包括阿茲海默症與帕金森氏症）後續臨床開發的潛力候選藥物。關鍵發現：兩組安全性：體格檢查、神經學檢查、生命徵象、心電圖及臨床實驗室參數均未見具臨床意義之變化。SUL-238 組與安慰劑組之不良事件發生率相當。所有不良事件強度皆屬輕度，或被判定與 SUL-238 無關。第一組別藥代動力學（2000 毫克，每日兩次）：SUL-238 吸收迅速，第 1 天與第 14 天達到血漿峰值濃度（Tmax）的平均時間分別為 1.25(±0.54)小時與 1.50(±0.53)小時。第 14 日平均終末消除半衰期(t1/2)為 3.50(±1.06)小時。SUL-238 平均谷濃度分別於第 8 日與第 14 日達 39.23(±24.31) ng/mL 及41.49(±18.20) ng/mL。第二組別藥代動力學（1500 毫克，每日三次）：SUL-238 吸收迅速，平均血漿濃度峰值達時（Tmax）分別為第 1 天 0.95(±0.16)小時與第 14 天 1.00(±0.00)小時。第 14 日平均終末消除半衰期(t1/2)：3.74(±1.84)小時。SUL-238 平均谷濃度分別於第 8 日與第 14 日達 57.98(±31.08)及 60.63(±64.14)ng/mLGEN 董事長 Abidin Gülmüş 表示：「SUL-238 在我們第一期試驗中取得的這些新正面結果，讓我們深受鼓舞，這標誌著在從生物學基礎上對抗阿茲海默症方面取得關鍵進展。」GEN 研發副總裁納迪爾·烏盧醫學博士補充道：「SUL-238 在本次多劑量遞增第一期試驗中展現卓越的安全性與藥代動力學特性，持續彰顯其作為強勢候選藥物之潛力，未來將針對神經退化性疾病（含阿茲海默症）未滿足之關鍵醫療需求推進臨床開發。」關於 SUL-238SUL-238 為首創性冬眠衍生物質小分子藥物，專注作用於細胞能量核心——線粒體。該藥物透過激活複合物 I/IV 支持線粒體生物能量代謝，並在神經退化性疾病、心血管疾病、腎臟疾病及加速衰老等多種前臨床模型中展現線粒體功能強化效果。SUL-238 具備穿越血腦屏障的能力，並已通過前臨床及臨床第一期試驗的全面安全性評估。GEN 公司從 Sulfateq B.V.取得 SUL-238 的神經退化性疾病應用授權。關於 GEN：GEN 創立於 1998 年，是土耳其領先的專業製藥公司，專注於開發跨治療領域的創新療法。透過重大研發投資與全球合作，GEN 致力推動全球醫療保健進步。該公司於符合GMP 認證的生產設施中研發製造高品質且具競爭力的產品，並透過兩座專用研發中心持續推進原創藥物開發的突破性努力。關於 Sulfateq：Sulfateq B.V. 是一家荷蘭早期生物科技公司，致力於與學術及產業研究機構建立戰略合作關係，加速創新藥物的開發進程。該公司已開發出一類新型小分子化合物——SUL 化合物，能有效維持線粒體健康狀態。更多資訊：www.genilac.com.trwww.sulfateqbv.com 聯絡資訊Bulutay Güneş企業品牌資深主管b.gunes@genilac.com Fatih Gören投資者關係經理f.goren@genilac.com SOURCE: GEN İlaç ve Sağlık Ürünleri A.Ş. Copyright 2025 亞太商訊 via SeaPRwire.com. All rights reserved. www.acnnewswire.com

EZVIZ 聚焦社群活動圓滿落幕，分享八個引起泰國家庭強烈共鳴的智慧家庭攝影機獲獎故事

hk_news

(SeaPRwire) -   曼谷，2025年12月2日 -- EZVIZ，全球智慧居家安全領導品牌，已正式結束其泰國特別活動「」，該活動從十月持續到十二月。在整個活動期間，全國各地的人們受邀分享他們生活中由EZVIZ攝影機記錄下的時刻—那些安全、關懷與連結緊密交織的時刻。在數百份感人投稿中，有八個故事獲選為優勝敘事，這些故事反映了泰國家庭的日常生活以及EZVIZ技術如何為他們服務。 這八個故事匯聚一堂，構成了此次活動的情感核心，每個故事都深入地展現了在泰國生活的不同層面中，安全感究竟意味著什麼。這些故事共同揭示了一個溫柔而多元的景象：關心心愛寵物的慰藉；在入室盜竊後重建信心的勇氣；子女遠距離守護年邁父母的孝心；職業父母透過螢幕與年幼子女保持聯繫的渴望；以及不同世代女性在家中相互保護的無聲力量。這些故事之所以被選中，不僅因為它們情感豐富，更因為它們以真實而人性化的方式，展現了安全與連結如何塑造泰國的日常生活節奏。 支撐這些生活經驗的是EZVIZ智慧居家攝影機的功能，這些攝影機旨在自然融入泰國家庭的日常生活。這些產品並非呈現技術功能，而是靜靜地在幕後運作，讓生活更輕鬆：在深夜有人靠近大門時提供清晰的夜視功能；在發生意外移動時發送實用警報；並允許即時雙向通話，以熟悉的聲音彌合距離。透過EZVIZ應用程式，使用者可以輕鬆地切換房間、與親人分享權限，或在旅行或工作期間查看家中狀況—這些小小的便利，共同創造了有意義的存在感。 隨著活動接近尾聲，這八個故事仍可在EZVIZ泰國的社群媒體頻道上瀏覽，繼續激勵並提醒社群我們之間相互連結的共同經驗。它們的持久影響力突顯了科技如何，在其最佳狀態下，能讓我們更貼近那些賦予生命意義的時刻。 聯絡方式： Charlene Li lixiaolan15@ezviz.com 圖片： 本文由第三方廠商內容提供者提供。SeaPRwire (https://www.seaprwire.com/)對此不作任何保證或陳述。 分類: 頭條新聞,日常新聞 SeaPRwire為公司和機構提供全球新聞稿發佈，覆蓋超過6,500個媒體庫、86,000名編輯和記者，以及350萬以上終端桌面和手機App。SeaPRwire支持英、日、德、韓、法、俄、印尼、馬來、越南、中文等多種語言新聞稿發佈。

AdipoLABs Opens New Regional Office, Signs Two MoUs With University of Cyberjaya to Advance Healthcare Innovation

acn

Partnership drives clinical research, hands-on student training, and access to cutting-edge medical technologiesPETALING JAYA, Malaysia, Dec 2, 2025 - (JCN Newswire via SeaPRwire.com) - AdipoLABs Co., Ltd. and Red & Blue Co., Ltd. from Korea, together with their Malaysian subsidiary, AdipoLABs Healthcare (M) Sdn Bhd, today officially opened the new AdipoLABs regional office for Asia-Pacific, marking a strategic expansion to strengthen its leadership in non- invasive healthcare and build a robust MedTech ecosystem in Malaysia and across ASEAN.As a research and development-focused medical company, its presence is expected to drive knowledge transfer, foster R&D collaboration, provide industry-standard training, and enhance the country’s preventive healthcare capabilities. Tocommemorate this milestone, the company also signed two Memoranda of Understanding (MoUs) with the University of Cyberjaya (UoC), formalising a partnership to advance healthcare innovation, clinical research, and talent development.“By uniting our hyperthermia technology with local expertise and academic rigour, we’ll expedite the adoption of advanced solutions and improve patient outcomes worldwide. We envision this collaboration as a blueprint for international healthcare partnerships,” said Mr. Han Sung-ho, CEO of AdipoLABs Co., Ltd.A cornerstone of the first MoU is a comprehensive internship programme with UoC’s Physiotherapy programmes under the Faculty of Health, offering six-month placements and potential job opportunities to give students invaluable real-world experience. Students from the Faculty of Health will gain hands-on expertise with AdipoLABs’ Pain Bot device, enhancingtheir skills in pain detection and treatment, while students from the School of Biomedical Engineering will support AdipoLABs’ technical operations, strengthening after-sales service and device maintenance.As part of the partnership, AdipoLABs will implement a strategic client engagement initiative, where interns may be placed at client facilities to demonstrate device effectiveness and provide on-site support. This initiative highlights the interns’ value, encourages potential permanent employment, and ensures optimal use of the technology. The collaboration also extends to clinical research, with UoC professors and students conducting studies on various AdipoLABs medical devices, generating evidence-based insights to be published in reputable journals and scientifically validating the technologies.“We’re thrilled to collaborate with the University of Cyberjaya to cultivate local talent and drive Malaysian healthcareinnovation. This partnership offers UoC students invaluable hands-on experience with technologies like Pain Bot. It also expands our clinical research, enhancing pain management solutions for patients across Malaysia and ASEAN. We are dedicated to empowering future healthcare leaders,” said Dr. Isaac R. Joseph, Director of AdipoLABs Healthcare (M) Sdn Bhd.In a parallel effort to advance physiotherapy education, AdipoLABs Malaysia, Red & Blue Co., Ltd., and UoC signed a second MoU focused on knowledge transfer and medical device donation. Under this agreement, AdipoLABs Malaysia willdonate a Pain Bot unit to UoC, giving students access to cutting-edge pain detection and treatment technology and enhancing their knowledge and skills in innovative musculoskeletal pain management methods.AdipoLABs, a Ministry of Health (MOH)-registered medical-device establishment under the Medical Device Authority(MDA), anchors this collaboration with proven regulatory credibility and a strong commitment to quality and innovation. Their certified standing reinforces UoC’s ambition to accelerate evidence-based research and industry-ready healthcare solutions.“AdipoLABs’ partnership with the University of Cyberjaya is more than a collaboration, it is a direct investment in the next generation of healthcare professionals. With the introduction of advanced rehabilitative technologies, our students gain access to international-standard tools and real-world innovation that will shape their confidence, competence, and future careers,” said Professor Dr. David Whitford, Vice-Chancellor of the University of Cyberjaya.Further strengthening this collaboration, Professor Dr. Yoo Seung-mo from South Korea, the inventor of the Pain Bot, will serve as an Adjunct Professor at UoC. Dr. Yoo will provide on-site training and ongoing remote mentorship, ensuringstudents receive the highest level of expertise in utilising the Pain Bot technology and applying advanced pain detection and treatment techniques.Together, UoC and AdipoLABs are positioned to drive forward Malaysia’s healthcare innovation agenda with greater confidence and impact.For more information on University of Cyberjaya or AdipoLABs Healthcare (M) Sdn Bhd, kindly visit: University of Cyberjaya – Premier University in Malaysia or adipolabs-msia.com – AdipoLABs Healthcare MalaysiaABOUT UNIVERSITY OF CYBERJAYA (UOC)The University of Cyberjaya is a premier institution located in Malaysia's first smart city, offering a transformative educational experience on a state-of-the-art, eco-friendly campus. The University was recently ranked in the top 1,000 universities in the world under the QSWorld University Rankings and is also currently ranked top 450 under the QS Asia University Rankings 2026.The University is renowned for its excellence in medicine, teaching, employability, facilities, and social responsibility. Additionally, itholds a Top 601+ ranking in the Times Higher Education Sustainability Impact Rankings, excelling in Top 200 for Good Health and Well-being (SDG 3).Founded in 2005 with a focus on medicine and pharmacy, the University has expanded to offer over 50 programmes across diverse fields such as medicine, health sciences, nursing, pharmaceutical sciences, psychology, business, and biomedical engineering. With a globalcommunity of over 10,000 students and over 13,000 alumni, the University is shaping future leaders who are making significant contributions to various industries. The University’ impact is reflected in its graduates, who have contributed to innovations in healthcareduring the COVID-19 pandemic, participated in international humanitarian missions, and made significant advancements across industries such as business and biomedical engineering.The University is guided by Chancellor Tan Sri Dato' Seri Dr. Noor Hisham Abdullah, a prominent figure in global healthcarefor World Health Organization (WHO) initiatives and former Director-General of the Malaysian Ministry of Health. Chairman Professor Tan Sri Dato' Dr. Mohd Amin Jalaludin, former Vice-Chancellor of the University of Malaya, provides strategic governance as Chairman of the Board of Governors. Under the leadership of Vice Chancellor Professor Dr. David Whitford, the University is strengthening itsglobal outlook and academic excellence. The university can be contacted at +603 8313 7000.About AdipoLABs Co., Ltd.AdipoLABs Co., Ltd. is a South Korean medical device company specialising in innovative hyperthermia cancer treatment technology. The company is the manufacturer of the Remission 1℃, a high-frequency hyperthermia device used in hospitals worldwide as an adjunct therapy for cancer treatment. With a commitment to research and development, AdipoLABs strives to improve patient outcomes andcontribute to a future free from the burden of disease. AdipoLABs has a global presence, with branches in India, China, and Malaysia.About AdipoLABs Healthcare (M) Sdn BhdAdipoLABs Healthcare (M) Sdn Bhd, established in Malaysia in 2018, is a subsidiary of AdipoLABs Co., Ltd. As the sole distributor of AdipoLABs medical devices in Malaysia and authorised representative for sales, marketing, and after-sales service throughout the ASEAN region, the company is committed to bringing innovative, non-invasive medical devices and innovative solutions to the Southeast Asian market. The company works closely with an international team of researchers, doctors, lab technicians, and engineers toprovide cutting-edge healthcare technology to the ASEAN market. Dr. Isaac R. Joseph and Mr. Moses Balagopal are the Directors and Co-founders of AdipoLABs Healthcare (M) Sdn Bhd.About Red & Blue Co., Ltd.Red & Blue Co., Ltd. is a South Korean company specialising in the development and distribution of advanced medical devices andhealthcare solutions. As a key partner of AdipoLABs Co., Ltd., Red & Blue Co., Ltd. is committed to supporting education and traininginitiatives that promote the effective use of innovative pain detection and pain treatment techniques. Dr. Yoo works closely with healthcare professionals and academic institutions to advance the field of pain management and improve patient outcomes.Issued by MNAIR PR Consultancy Sdn Bhd on behalf of University of Cyberjaya and AdipoLABs Healthcare (M) Sdn Bhd Contacts for Media Enquiries:MNAIR PR Consultancy Sdn Bhd Ameera HaniAssociate Director, Public Relations+6014 2243296ameera@mnairpr.comUniversity of Cyberjaya (UoC) Ehya NadzeriCommunicationsCyberjaya Education Group Berhad gcmc@cyberjaya.edu.my Copyright 2025 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

君聖泰醫藥公佈HTD1801與達格列淨的頭對頭III期臨床研究結果 展現控糖優勢及心血管代謝優效獲益

acn

香港, 2025年12月2日 - (亞太商訊 via SeaPRwire.com) - 試驗數據再次驗證，HTD1801靶向2型糖尿病發生及發展的根源性問題，實現更全面的心血管代謝綜合獲益。君聖泰醫藥（股票代碼：2511.HK），一家專注于開發多功能創新療法，以解決代謝性慢病未滿足臨床需求的創新藥公司，宣佈HTD1801在2型糖尿病（T2DM）患者中開展的與達格列淨頭對頭的臨床III期試驗（HARMONY）取得了積極的結果，試驗達到主要終點，並在多項關鍵心血管代謝指標的改善上優於達格列淨。HARMONY（NCT06415773）是一項隨機、雙盲、陽性藥物對照的III期臨床研究（N=369），旨在評估HTD1801與達格列淨相比，在二甲雙胍治療後血糖控制不佳的成年T2DM患者中的有效性與安全性。研究的主要終點為：治療24周後HbA1c相對於基線的變化（非劣效界值為0.4%）。次要終點包括多項心血管代謝指標。- 達成主要終點：HTD1801治療24周後，HbA1c的最小二乘（LS）均值變化為-1.12%，達格列淨組為-0.93%（LS均值差異：-0.20%；95% CI：-0.37 ~ -0.03；P < 0.001）。- 達成多項次要終點：相較達格列淨，HTD1801在LDL-C與non-HDL-C降低方面明顯更優，需要新增或強化他汀類治療的患者比例也顯著低於達格列淨組。HTD1801還在多個心血管代謝指標的改善上優於達格列淨，如治療後有更高比例的患者達到HbA1c<7.0%的控制目標，以及更大的Lp(a)降幅。- HTD1801具有良好的安全性與耐受性，嚴重不良事件的發生率為3.8%（達格列淨組為4.4%）。HTD1801組最常見的不良事件為輕至中度胃腸道不良反應，且未見嚴重低血糖事件。綜合而言，相較於SGLT2抑制劑，HTD1801通過同時調控代謝與炎症通路，更精准地靶向T2DM的核心病理機制，可為T2DM患者帶來更為全面的臨床獲益。繼 SYMPHONY-1和SYMPHONY-2試驗之後，HARMONY是HTD1801第三項取得積極結果的III期試驗，進一步驗證了其成為心腎代謝疾病（CKM）基礎治療藥物的強大潛力。君聖泰醫藥計畫於今年內啟動HTD1801項目的新藥上市申請（NDA）。該臨床試驗的主要研究者，前國際糖尿病聯盟（IDF）副主席、北京大學糖尿病中心主任、北京大學人民醫院內分泌和代謝科主任紀立農教授指出："HARMONY研究數據顯示HTD1801降糖效果優於降糖藥物SGLT2抑制劑達格列淨，同時比具有已經被證明有顯著心腎保護作用的達格列淨有更強的降低導致動脈粥樣硬化性心血管的低密度脂蛋白的作用，並減少他汀類藥物的治療需求。這提示HTD1801 可能具有更強的改善動脈粥樣硬化性心血管疾病的潛力。我們非常期待該藥物上市，使這項創新療法惠及患者。"君聖泰醫藥的創始人、董事長兼首席執行官劉利平博士表示："HARMONY研究數據讀出是HTD1801全球開發進程中的又一項關鍵里程碑。隨著三項III期臨床試驗的相繼成功完成，作為全球首創且兼具"一藥多效"特性的創新藥物，HTD1801持續展現其治療潛力，有望補充甚至突破SGLT2抑制劑的治療邊界，為T2DM患者提供更全面的治療方案。"關於HTD1801HTD1801是一款全球首創的新分子實體，旨在解決心腎代謝系統疾病（CKM）的未滿足臨床需求。HTD1801作為單一分子，是具有獨特雙機制的口服抗炎及代謝調節劑（AIMM），通過啟動AMPK及抑制NLRP3炎症小體發揮其生物學活性；這種互補協同的雙機制作用可有效解決代謝問題。全球多項臨床結果驗證HTD1801具有"一藥多效"的特性，能夠為患者帶來綜合獲益，包括改善胰島素敏感性、血糖控制、血脂降低、腎臟保護、體重減輕、肝臟獲益及抗炎等。基於此，HTD1801有潛力成為CKM領域的基礎性治療藥物。 Copyright 2025 亞太商訊 via SeaPRwire.com. All rights reserved. www.acnnewswire.com